Elevance Health reported third-quarter 2026 operating revenue of $50.4 billion, up 0.7% from a year earlier, and diluted earnings per share of $6.27, up 17.9% from $5.32, which included a net non-operating benefit of $1.85 per share. The company raised its full-year 2026 diluted EPS guidance to at least $22.00 and adjusted diluted EPS guidance to at least $29.00, though the Health Benefits operating gain fell 27.5%. For shareholders, the higher outlook is the main change, while nine-month diluted EPS of $21.01 was down 7.3% from the prior year.
Third-quarter operating revenue was $50.4 billion, up 0.7% from $50.1 billion a year earlier.
Diluted EPS was $6.27 versus $5.32 a year earlier; adjusted diluted EPS was $6.99 versus $6.03.
Full-year 2026 diluted EPS guidance was raised to at least $22.00; adjusted diluted EPS guidance was raised to at least $29.00.
Health Benefits operating gain fell 27.5% to $0.4 billion, and a $1.72 quarterly dividend was declared for payment on December 18, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Elevance Health's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$199.12B
+12.5%
$25.21
-1.8%
2.8%
FY2024
$177.01B
+3.3%
$25.68
+1.8%
3.4%
FY2023
$171.34B
+9.4%
$25.22
+3.9%
3.5%
FY2022
$156.59B
+13.0%
$24.28
-2.7%
3.8%
FY2021
$138.64B
+13.8%
$24.95
+38.8%
4.4%
Frequently asked questions
When is Elevance Health's next earnings date?
Elevance Health has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Elevance Health earn last quarter?
For the quarter ended Sep 2026, Elevance Health reported diluted EPS of $6.27 (+17.9% year over year) on revenue of $51.43B (+1.4%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.